2015 Influx Of Ebola Money Masks Declines In R&D Funding For Other Infectious, Neglected Diseases, G-FINDER Report Shows
Nature: Ebola funding surge hides falling investment in other neglected diseases
“Global funding for research on neglected diseases — which include tuberculosis, HIV/AIDS, and malaria — is at its lowest level since 2007, according to the annual G-FINDER investment report by Policy Cures Research, a health policy analysis firm in Sydney, Australia. But that total — just over US$3 billion for 2015, the latest year for which figures are available — does not include a rapid burst of funding for research into Ebola to tackle the outbreak in West Africa. Investments in Ebola and other African viral hemorrhagic fevers shot up to $631 million in 2015 — more than was spent on any other neglected disease except HIV/AIDS…” (Ross et al., 2/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.